Related Experiment Video
Updated: May 10, 2026

11:03
Robotic Left Hepatectomy using Indocyanine Green Fluorescence Imaging for an Intrahepatic Complex Biliary Cyst
Published on: June 24, 2022
5.4K
Robotic-assisted single-port system for pulmonary lobectomy: A prospective feasibility study
Michael Zervos1, Bernard J Park2, M Blair Marshall3
1Department of Cardiothoracic Surgery, NYU Langone Health, New York, NY.
The Journal of Thoracic and Cardiovascular Surgery
|April 11, 2025
Summary
Robotic single-port (SP) subcostal lobectomy is feasible and safe for pulmonary procedures. This approach achieved complete tumor resection with acceptable outcomes, though further research is needed for comparison to multiport methods.
Area of Science:
- Thoracic Surgery
- Surgical Oncology
- Robotic Surgery
Background:
- Pulmonary lobectomy is a standard surgical procedure for lung cancer.
- Minimally invasive techniques like robotic surgery aim to improve patient outcomes.
- The da Vinci single-port (SP) System offers a uniportal approach, potentially reducing invasiveness.
Purpose of the Study:
- To evaluate the feasibility and safety of the da Vinci SP System for pulmonary lobectomy.
- To assess the perioperative and oncologic outcomes of this novel approach.
- To determine if a subcostal, uniportal robotic lobectomy is a viable alternative.
Main Methods:
- A prospective, multicenter, single-arm clinical study was conducted.
- Nineteen patients underwent robotic-assisted SP subcostal lobectomy for pulmonary lobectomy.
- The study evaluated safety, feasibility, and oncologic outcomes.
Main Results:
- All 19 SP lobectomy procedures were successfully completed without conversion to other approaches.
- No intraoperative adverse events or device issues were recorded.
- Complete tumor resection (R0) was achieved in 100% of cases, with extensive nodal sampling.
Conclusions:
- Robotic SP subcostal lobectomy is a feasible and safe procedure for pulmonary lobectomy.
- The approach demonstrates acceptable perioperative and oncologic quality outcomes.
- Further research is required to establish its clinical benefits over standard multiport robotic lobectomy.

